Evidence map›Paper›PMID 31848688›Full record

ArticlePflugers Archiv : European journal of physiology2020

RBP2 stabilizes slow Cav1.3 Ca

Nadine J Ortner, Alexandra Pinggera, Nadja T Hofer, Anita Siller, Niels Brandt, Andrea Raffeiner, Kristina Vilusic, Isabelle Lang, Kerstin Blum, Gerald J Obermair and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Inactivation of CaV1 and CaV2 channels.The Journal of general physiology · 2025
    Review
  3. Article
  4. Article
  5. CaBritish journal of pharmacology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Excess extracellular KCommunications biology · 2021
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Nadine J OrtnerDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria. nadine.ortner@uibk.ac.at.ORCID 0000-0003-3882-3283
Alexandra PinggeraDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
Nadja T HoferDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
Anita SillerDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
Niels BrandtDepartment of Biophysics and CIPMM, Saarland University, Homburg, Germany.
Andrea RaffeinerInstitute of Biochemistry, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
Kristina VilusicDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
Isabelle LangDepartment of Biophysics and CIPMM, Saarland University, Homburg, Germany.
Kerstin BlumDepartment of Biophysics and CIPMM, Saarland University, Homburg, Germany.
Gerald J ObermairDivision of Physiology, Medical University Innsbruck, Innsbruck, Austria.
Eduard StefanInstitute of Biochemistry, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
Jutta EngelDepartment of Biophysics and CIPMM, Saarland University, Homburg, Germany.
Jörg StriessnigDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria. joerg.striessnig@uibk.ac.at.
Universität Innsbruck · ATSaarland University · DEInnsbruck Medical University · AT

Funding

Austrian Science Fund FWF F4415Austrian Science Fund FWF P 27809Austrian Science Fund FWF P27809Austrian Science Fund FWF P 30441Austrian Science Fund FWF W11010
6 · The paper itself

Abstract

Cav1.3 L-type Ca

Indexed as

Action PotentialsAnimalsBinding SitesCalcium Channels, L-TypeFemaleHair Cells, Auditory, InnerHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsIon Channel GatingMaleMiceProtein BindingCacna1d protein, mouseCalcium Channels, L-TypeIntracellular Signaling Peptides and ProteinsRimbp2 protein, mouseCav1.3InactivationInner hair cellsL-type Ca2+ channelRibbon synapseRIM-binding protein

Identifiers

PMID31848688
PMCPMC6960213
OpenAlexW2996168650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.